Gabrielle Zamagias


Gabrielle Zamagias
Special Projects, Partnerships
Gabrielle joined Medopad in 2018 in a business development role responsible for developing and executing an international strategy across Medopad’s core verticals. Gabrielle is responsible for leading Medopad’s partnerships with both the Royal Wolverhampton NHS Trust and the Royal Free Hospital. In addition to managing these relationships, Gabrielle works with insurance, reinsurance, and pharmaceutical companies on developing strategic partnerships.
Prior to Medopad, Gabrielle ran the business development and marketing team at TeleTracking Technologies, a healthcare technology company.
Gabrielle holds a Bachelor’s Degree in Integrated Marketing Communications and Business from Pepperdine University.

dont miss

Remote Patient Monitoring: Bringing the Hospital into the Home

Patients with rare and chronic disease spend 95% of their time outside hospital, where clinicians typically have no or intermittent access to patient health data.
Here, we explore how a remote patient monitoring solution can be applied within the care pathway for oncology, to improve visibility of patient progress, impact patient engagement, and improve pathway efficiencies. Oncology monitoring at King’s College Hospital, HCA, and Sussex Cancer Centre will be explored.


  • Simon Walker-Samuel: Speaking at the Oncology Convention

    Simon Walker-Samuel
    University College London

    Using medical imaging with machine learning to develop efficient tools for diagnosing cancer

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • Clare Hutton & Peter Colley: Speaking at the Oncology Convention

    Clare Hutton & Peter Colley
    Hull & East Yorkshire Hospitals NHS Trust

    The Implementation & Development of IMRT in Hull

  • Dr Simon Crabb: Speaking at the Oncology Convention

    Dr Simon Crabb
    University of Southampton

    Novel Therapeutic Strategies for Advanced Prostate Cancer

  • Khurum Khan: Speaking at the Oncology Convention

    Khurum Khan
    Royal Marsden NHS Foundation Trust

    Biomarkers of response and/or resistance to targeted therapies in refractory mCRC